Captor Medical has developed the CAPTOR™ platform, a device designed for the effective removal of intravascular thrombus in patients experiencing acute ischemic stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE). This technology addresses the critical need for timely and efficient thrombus extraction to improve patient outcomes and reduce the risk of long-term complications.
Funding
$400K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Acute ischemic stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE) require rapid removal of intravascular thrombi to improve patient outcomes and reduce long-term complications. Current methods may not always be efficient or effective in extracting these thrombi.
Solution
Captor Medical offers the CAPTOR™ platform, a device engineered for the efficient removal of intravascular thrombus in patients experiencing acute ischemic stroke, DVT, and PE. The platform aims to redefine the standard of care by providing a solution for timely and effective thrombus extraction. The CAPTOR™ platform is designed to address the critical need for improved thrombus management, potentially leading to better patient outcomes and a reduced risk of lasting complications associated with these conditions.
Target Audience
The primary target audience includes interventional radiologists, vascular surgeons, and other medical professionals involved in the treatment of acute ischemic stroke, DVT, and PE.
Features
- Device designed for removing intravascular thrombus
- Application for acute ischemic stroke (AIS)
- Application for deep vein thrombosis (DVT)
- Application for pulmonary embolism (PE)